Literature DB >> 8824716

Autoreactive epitopes within the human alpha-enolase and their recognition by sera from patients with endometriosis.

M Walter1, H Berg, F A Leidenberger, K W Schweppe, W Northemann.   

Abstract

Patients with endometriosis significantly develop autoantibodies directed against endometrial proteins, which may be involved in the aetiology of this gynaecological disease. Based on standard Western blot analysis, a 48 kDa protein was localized in the soluble protein extract of endometrial adenocarcinoma cells using sera from patients with clinically staged endometriosis and identified as the glycolytic enzyme alpha-enolase. The corresponding cDNA coding for the human alpha-enolase was isolated from a human endometrial cDNA library and cloned into the vector pH6EX3, allowing the efficient expression of recombinant human alpha-enolase with an N-terminal histidine-hexapeptide as affinity ligand in Escherichia coli. The purified recombinant human alpha-enolase was evaluated as a specific antigenic tool for the diagnostic measurement of antiendometrial antibodies in sera from patients with endometriosis. With selected endometriosis sera, two linear autoreactive epitopes were localized within the recombinant human alpha-enolase using epitope mapping techniques, and they were characterized.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8824716     DOI: 10.1016/s0896-8411(95)80027-1

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

1.  Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN).

Authors:  H Wakui; H Imai; A Komatsuda; A B Miura
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  A Predictive Role of Autoantibodies Against the Epitope aa168-183 of ENO1 in the Occurrence of Miscarriage Related to Thyroid Autoimmunity.

Authors:  Xiaoqing He; Yifu Liu; Haoyu Wang; Wei Sun; Yihan Lu; Zhongyan Shan; Weiping Teng; Jing Li
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

3.  Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.

Authors:  Michael P Stany; Vinod Vathipadiekal; Laurent Ozbun; Rebecca L Stone; Samuel C Mok; Hui Xue; Takashi Kagami; Yuwei Wang; Jessica N McAlpine; David Bowtell; Peter W Gout; Dianne M Miller; C Blake Gilks; David G Huntsman; Susan L Ellard; Yu-Zhuo Wang; Pablo Vivas-Mejia; Gabriel Lopez-Berestein; Anil K Sood; Michael J Birrer
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

Review 4.  Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders.

Authors:  Grazyna Adamus
Journal:  Front Immunol       Date:  2017-04-28       Impact factor: 7.561

5.  Amoxicillin Haptenation of α-Enolase is Modulated by Active Site Occupancy and Acetylation.

Authors:  Juan M González-Morena; Francisco J Sánchez-Gómez; Yolanda Vida; Ezequiel Pérez-Inestrosa; María Salas; María I Montañez; Alessandra Altomare; Giancarlo Aldini; María A Pajares; Dolores Pérez-Sala
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

6.  Urinary Biomarkers for Detection of Clinical Endometriosis or Adenomyosis.

Authors:  Wei-Chun Chen; Chao-Min Cheng; Wan-Ting Liao; Ting-Chang Chang
Journal:  Biomedicines       Date:  2022-04-01

7.  Circulating antibodies to α-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy.

Authors:  Yukihiro Kimura; Naoto Miura; Hanna Debiec; Hiroyuki Morita; Harutaka Yamada; Shogo Banno; Pierre Ronco; Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2016-02-01       Impact factor: 2.801

Review 8.  Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies?

Authors:  Grazyna Adamus
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.